Prognostic features of patients with myelodysplastic syndromes aged < 50 years: Update of a single-institution experience

Leukemia and Lymphoma

Volumn 53, Issue 12, 2012, Pages 2439-2443

  Breccia, Massimo ^a   Finsinger, Paola ^a   Loglisci, Giuseppina ^a   Santopietro, Michelina ^a   Salaroli, Adriano ^a   Serrao, Alessandra ^a   Latagliata, Roberto ^a   Volpicelli, Paola ^a   Petrucci, Luigi ^a   Nanni, Mauro ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Myelodysplastic syndromes; Overall survival; Prognosis; Younger

Indexed keywords

BENZENE; MUTAGENIC AGENT; SOLVENT;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; OCCUPATIONAL EXPOSURE; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SCORING SYSTEM; SEX DIFFERENCE; TRISOMY 8;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; BENZENE; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MONOSOMY; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PROGNOSIS; SOLVENTS; SURVIVAL ANALYSIS; TRISOMY; YOUNG ADULT;

EID: 84868348765     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.698738     Document Type: Article

References (18)

1. Konrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 2010; 24: 443-457.
2. Germing U, Strupp C, Kungden A, et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004; 89: 905-910.
3. Fenaux P, Preudhomme C, Helene Estienne M, et al. D e novo myelodysplastic syndromes in adults aged 50 or less. A report on 37 cases. Leuk Res 1990; 14: 1053-1059.
4. Chang KL, O' Donnell MR, Slovak ML, et al. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. Leukemia 2002; 16: 623-631. (Pubitemid 34449743)
5. Kuendgen A, Strupp C, Aivado M, et al. M yelodysplastic syndromes in patients younger than age 50. J Clin Oncol 2006; 34: 5358-5365. (Pubitemid 46623166)
6. Breccia M, Mengarelli A, Mancini M, et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leuk Res 2005; 29: 749-754. (Pubitemid 40779481)
7. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199. (Pubitemid 12073508)
8. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937-951.
9. Greenberg P, Cox C, LeBeau MM, et al. I nternational scoring system for evaluating prognosis in myelodysplastic syndrome. Blood 1997; 89: 2079-2088. (Pubitemid 27132124)
10. Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndrome. J Clin Oncol 2007; 25: 3503-3510. (Pubitemid 47315575)
11. Kantarjian H, O' Brien S, Ravandi F, et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 2008; 113: 1351-1356.
12. Gologan R. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania. Leuk Res 2010; 34: 1442-1446.
13. Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 2005; 19: 767-775. (Pubitemid 40663096)
14. Oguma S, Yoshida Y, Uchino H, et al. C linical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases. Leuk Res 1995; 19: 219-225.
15. Matsuda A, Germing U, Jinnai I, et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 2005; 106: 2633-2640. (Pubitemid 41510734)
16. Lau LG, Chng WJ, Liu TC, et al. Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and International prognostic scoring system. Ann Acad Med Singapore 2004; 33: 589-595. (Pubitemid 39626964)
17. Paydas S. Young age MDS: differences between Western and Eastern countries. Leuk Res 2006; 30: 362. (Pubitemid 43053235)
18. Alessandrino EP, Amadori S, Barosi G, et al. Evidence and consensus based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. Haematologica 2002; 87: 1286-1306. (Pubitemid 36005304)